Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6685227 | 7337755 | F | 6685227-0 | 20070901 | 20100408 | 20100416 | EXP | JP-ABBOTT-10P-087-0635118-00 | ABBOTT LABORATORIES | 70 | YR | F | Y | 20100416 | GERMANY |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6685227 | 1013520137 | PS | LIPIDIL | 1 | ORAL | UNKNOWN | 19304 | ||||
| 6685227 | 1013520138 | SS | ACTOS | 1 | ORAL | UNKNOWN | |||||
| 6685227 | 1013520139 | SS | VOGLIBOSE | 2 | ORAL | UNKNOWN | |||||
| 6685227 | 1013520140 | SS | DIOVAN | 1 | ORAL | UNKNOWN | |||||
| 6685227 | 1013520141 | SS | ADALAT | 1 | ORAL | UNKNOWN | |||||
| 6685227 | 1013520142 | SS | ALLELOCK | 2 | ORAL | UNKNOWN | |||||
| 6685227 | 1013520143 | SS | NIPOLAZIN | 2 | ORAL | UNKNOWN | |||||
| 6685227 | 1013520144 | SS | URSO 250 | 1 | ORAL | UNKNOWN | |||||
| 6685227 | 1013520145 | SS | EPL | 2 | ORAL | UNKNOWN | |||||
| 6685227 | 1013520146 | SS | JINSO-IN | 2 | ORAL | UNKNOWN | |||||
| 6685227 | 1013520147 | SS | JINSO-IN | 2 | UNKNOWN | ||||||
| 6685227 | 1013520148 | SS | SMOUSAIKOTOUKAKIKYOUSEKKOU | 2 | ORAL | UNKNOWN | |||||
| 6685227 | 1013520149 | SS | SMOUSAIKOTOUKAKIKYOUSEKKOU | 2 | UNKNOWN | ||||||
| 6685227 | 1013520150 | SS | KAKKON-TO | 2 | ORAL | UNKNOWN | |||||
| 6685227 | 1013520151 | SS | KAKKON-TO | 2 | UNKNOWN | ||||||
| 6685227 | 1013520152 | SS | KAKKONTOUKASENKYUUSHINI | 2 | ORAL | UNKNOWN | |||||
| 6685227 | 1013520153 | SS | KAKKONTOUKASENKYUUSHINI | 2 | UNKNOWN | ||||||
| 6685227 | 1013520154 | SS | VOALLA | 2 | TRANSDERMAL | UNKNOWN |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6685227 | 1013520137 | HYPERLIPIDAEMIA |
| 6685227 | 1013520138 | DIABETES MELLITUS |
| 6685227 | 1013520139 | DIABETES MELLITUS |
| 6685227 | 1013520140 | HYPERTENSION |
| 6685227 | 1013520141 | HYPERTENSION |
| 6685227 | 1013520142 | ECZEMA |
| 6685227 | 1013520143 | ECZEMA |
| 6685227 | 1013520144 | LIVER DISORDER |
| 6685227 | 1013520145 | LIVER DISORDER |
| 6685227 | 1013520146 | ANTITUSSIVE THERAPY |
| 6685227 | 1013520147 | DIURETIC THERAPY |
| 6685227 | 1013520148 | ANTITUSSIVE THERAPY |
| 6685227 | 1013520149 | DIURETIC THERAPY |
| 6685227 | 1013520150 | ANTITUSSIVE THERAPY |
| 6685227 | 1013520151 | DIURETIC THERAPY |
| 6685227 | 1013520152 | ANTITUSSIVE THERAPY |
| 6685227 | 1013520153 | DIURETIC THERAPY |
| 6685227 | 1013520154 | ECZEMA |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6685227 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 6685227 | DIABETES MELLITUS |
| 6685227 | ECZEMA |
| 6685227 | HEPATIC FUNCTION ABNORMAL |
| 6685227 | INTERSTITIAL LUNG DISEASE |
| 6685227 | NASOPHARYNGITIS |
| 6685227 | PYREXIA |
| 6685227 | RENAL IMPAIRMENT |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6685227 | 1013520138 | 20070901 | 20071020 | ||
| 6685227 | 1013520139 | 20070901 | 20071020 | ||
| 6685227 | 1013520140 | 20060101 | |||
| 6685227 | 1013520142 | 20070810 | |||
| 6685227 | 1013520143 | 20070810 | |||
| 6685227 | 1013520144 | 20070901 | |||
| 6685227 | 1013520145 | 20070901 | |||
| 6685227 | 1013520146 | 20070901 | |||
| 6685227 | 1013520148 | 20070901 | |||
| 6685227 | 1013520150 | 20070901 | |||
| 6685227 | 1013520152 | 20070901 | |||
| 6685227 | 1013520154 | 20070810 |